On March 22, 2025, the National Center for Tumor Diseases (NCT) Heidelberg invites you to the 20th Cancer Patient Day. This year, the event will once again take place in person, and the lectures will also be broadcast live online. The Patient Day offers specialist lectures, a panel discussion and expert forums on various types of cancer. In addition, patients, relatives and all interested parties can talk to numerous self-help groups and partners of the NCT Heidelberg at information stands. Registration is possible until March 17 at this link: https://indico.dkfz.de/e/Krebspatiententag2025

The National Center for Tumor Diseases (NCT) Heidelberg is a joint institution of the German Cancer Research Center (DKFZ), the University Hospital Heidelberg (UKHD), the Heidelberg Medical Faculty of the Heidelberg University and the Thoraxklinik Heidelberg.

The 20th Cancer Patient Day at the NCT Heidelberg will take place on March 22, 2025 from 9:00 a.m. to 2:30 p.m. at Heidelberg University Hospital. After a series of online events due to the pandemic, patients, their relatives and anyone else who is interested will once again be able to talk directly to medical experts and self-help groups. The location is new: the Patient Day is using lecture halls and seminar rooms at the Surgical Clinic and the Center for Internal Medicine (Krehl Clinic) at the Neuenheimer Feld in Heidelberg. In addition, the lectures will be streamed live online.

The specialist lectures in the morning offer generally understandable insights into current advances in oncological research and therapy, as well as into supportive offers for patients. A panel discussion will address the topic “Patients become partners: shaping research together”. In addition, the self-help groups and patient representation at the NCT Heidelberg will introduce themselves.

In the expert forums in the early afternoon, medical specialists and representatives of self-help groups will address specific and personal questions from participants, divided by disease. In addition, visitors can visit information booths and talk to many self-help groups and other partners about how to deal with the disease at the information tables during the Cancer Patient Day.

Registration for the 20th Cancer Patient Day at the NCT Heidelberg is possible online at this link until March 17. https://indico.dkfz.de/e/Krebspatiententag2025

The following companies are supporting the event as sponsors: MSD Sharp & Dohme, Pierre Fabre Pharma, Janssen-Cilag, AstraZeneca, BMT Braun, Boehringer Ingelheim Pharma, Danone Deutschland, Novartis Pharma, Takeda Pharma Vertrieb and Helixor Heilmittel.

+++

Media representatives are very welcome to attend the Cancer Patient Day. Please register by email with Martin Staiger, martin.staiger(at)nct-heidelberg.de, see below for further contact details.

+++

Specialist lectures

• PD Dr. Thomas Held: Radiotherapy
• Prof. Dr. Dr. Guy Ungerechts: Immunotherapy
• PD Dr. Mohammed Al-Saeedi: Oncological Surgery
• Prof. Dr. Stefan Fröhling: Molecular Oncology
• Anne Weininger: Counselling Services
• Panel discussion “Patients become partners: shaping research together”; with Prof. Dr. Stefan Fröhling, PD Dr. Markus Herrmann, Dr. Cindy Körner, Imke Veit-Schirmer, moderated by PD Dr. Rosa Klotz

Expert forums

• Breast cancer
• Bone and soft tissue tumors (sarcomas), cancers of unknown primary origin (CUP)
• Cancer of the digestive organs, endocrine and neuroendocrine tumors
• Brain tumors
• Lung cancer and tumors of the chest
• Blood cancer and cancer of the hematopoietic system (leukemia, lymphoma and multiple myeloma)
• Skin cancer
• Gynecological tumors
• Tumors of the prostate, bladder, kidneys, testicles and penis
• Head and neck tumors

Registration information and contact
20th Cancer Patient Day of the NCT Heidelberg
March 22, 2025
9:00 a.m. to 2:30 p.m.
Heidelberg University Hospital
Surgical Clinic and Center for Internal Medicine (Krehl Clinic)
Registration online by March 17 at https://indico.dkfz.de/e/Krebspatiententag2025

For security reasons, only a limited number of seats are available. Participation is free of charge. Food and drinks will be provided.

National Center for Tumor Diseases (NCT) Heidelberg
Training and Events
Phone: +49 (0)6221 56-36091
Email: nct.events@nct-heidelberg.de
Organizer: Heidelberg University Hospital

Donations
Donations to cover costs are welcome.
Account: 7 421 500 429
Bank: BW-Bank Stuttgart
IBAN: DE64 6005 0101 7421 5004 29
BIC: SOLADEST600
Purpose: D.10081910 / Patiententag 2025

A picture for the press release is available free of charge at:
https://www.nct-heidelberg.de/fileadmin/media/nct-heidelberg/news/pressemitteilungen/NCT_HD_Patiententag2025.jpg

Terms of use for images accompanying press releases
Use is free of charge. The NCT Heidelberg permits one-time use in connection with reporting on the subject of the press release. Please credit the copyright “NCT Heidelberg”. The image material may only be passed on to third parties after prior consultation with NCT Communications (Tel.: +49 6221 42-1755, E-Mail: martin.staiger@nct-heidelberg.de). Use for commercial purposes is prohibited.

Contact for the press:
Dr. Martin Staiger
National Center for Tumor Diseases (NCT) Heidelberg
Communication and Events
Im Neuenheimer Feld 460
69120 Heidelberg
Phone: +49 6221 42-1755
E-mail: martin.staiger(at)nct-heidelberg.de
www.nct-heidelberg.de

The National Center for Tumor Diseases (NCT) Heidelberg
The National Center for Tumor Diseases (NCT) Heidelberg is a joint institution of the German Cancer Research Center (DKFZ), the University Hospital Heidelberg (UKHD), the Heidelberg Medical Faculty of the Heidelberg University and the Thoraxklinik Heidelberg. The aim of the NCT Heidelberg is to transfer promising approaches from cancer research into clinical practice as quickly as possible, and thus to benefit patients. This applies to both diagnosis and treatment, in aftercare or prevention. Participation in clinical studies opens up access to innovative therapies. The NCT Heidelberg is thus a leader in transferring new research results from the laboratory to the clinic The NCT Heidelberg, founded in 2004, is part of the NCT with further locations in Berlin, Dresden, SouthWest (Tübingen-Stuttgart/Ulm), WERA (Würzburg, Erlangen, Regensburg, Augsburg) and West (Essen/Cologne).
 

German Cancer Research Center (DKFZ)
With more than 3,000 employees, the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) is Germany’s largest biomedical research institute. DKFZ scientists identify cancer risk factors, investigate how cancer progresses and develop new cancer prevention strategies. They are also developing new methods to diagnose tumors more precisely and treat cancer patients more successfully. The DKFZ's Cancer Information Service (KID) provides patients, interested citizens and experts with individual answers to questions relating to cancer.

To transfer promising approaches from cancer research to the clinic and thus improve the prognosis of cancer patients, the DKFZ cooperates with excellent research institutions and university hospitals throughout Germany:

• National Center for Tumor Diseases (NCT, 6 sites)  
• German Cancer Consortium (DKTK, 8 sites)
• Hopp Children's Cancer Center (KiTZ) Heidelberg
• Helmholtz Institute for Translational Oncology (HI-TRON Mainz) - A Helmholtz Institute of the DKFZ
• DKFZ-Hector Cancer Institute at the University Medical Center Mannheim
• National Cancer Prevention Center (jointly with German Cancer Aid) 

The DKFZ is 90 percent financed by the Federal Ministry of Education and Research and 10 percent by the state of Baden-Württemberg. The DKFZ is a member of the Helmholtz Association of German Research Centers.

Heidelberg University Hospital and Faculty of Medicine: Internationally Renowned Patient Care, Research and Teaching

Heidelberg University Hospital (Universitätsklinikum Heidelberg, UKHD) is one of the largest and most prestigious medical centers in Germany. The Medical Faculty of Heidelberg University (Medizinische Fakultät Heidelberg, MFHD) belongs to the internationally renowned biomedical research institutions in Europe. Both institutions have the common goal of developing new therapies and implementing them rapidly for patients. Heidelberg University Hospital and the Medical Faculty of Heidelberg University employs around 14.500 employees and is committed to providing trainings and qualifications. Every year, around 86,000 patients and more than 1.100.000 outpatient cases are treated in more than 50 clinical departments with almost 2.500 beds.

Together with the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) and the German Cancer Aid, the UKHD established the first National Center for Tumor Diseases (NCT) in Heidelberg. The goal is to provide care at the highest level as an oncology center of excellence and to rapidly transfer promising approaches from cancer research to the hospital. In addition, the UKHD operates in partnership with the DKFZ and the University of Heidelberg the Hopp Children’s Cancer center Heidelberg (KiTZ), a unique and nationally known therapy and research center for oncological and hematological diseases in children and adolescents.

The Heidelberg Curriculum Medicinale (HeiCuMed) is one of the top medical training programs in Germany. Currently, there are about 4.000 future physicians studying in Heidelberg.